186 related articles for article (PubMed ID: 30642195)
1. Silicone oil droplets in repackaged anti-vascular endothelial growth factors for intravitreal injections: In search of the main source of contamination.
Olea JL; Gómez-Resa M; Cervera-Peris MM; Aragón JA
Eur J Ophthalmol; 2020 Jul; 30(4):774-779. PubMed ID: 30642195
[TBL] [Abstract][Full Text] [Related]
2. CONTAMINATION OF ANTI-VEGF DRUGS FOR INTRAVITREAL INJECTION: How Do Repackaging and Newly Developed Syringes Affect the Amount of Silicone Oil Droplets and Protein Aggregates?
Schargus M; Werner BP; Geerling G; Winter G
Retina; 2018 Oct; 38(10):2088-2095. PubMed ID: 28841584
[TBL] [Abstract][Full Text] [Related]
3. Prospective Study of Silicone Oil Microdroplets in Eyes Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in 3 Different Syringes.
Thompson JT
Ophthalmol Retina; 2021 Mar; 5(3):234-240. PubMed ID: 32735904
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Presumed Silicone Oil Droplets in the Vitreous Cavity After Intravitreal Bevacizumab Injection With Insulin Syringes.
Khurana RN; Chang LK; Porco TC
JAMA Ophthalmol; 2017 Jul; 135(7):800-803. PubMed ID: 28617905
[TBL] [Abstract][Full Text] [Related]
5. Silicone oil-free syringes, siliconized syringes and needles: quantitative assessment of silicone oil release with drugs used for intravitreal injection.
Melo GB; da Cruz NFS; do Monte Agra LL; Emerson GG; Lima LH; Linkuviene V; Maia M; Farah ME; Carpenter JF; Rodrigues EB; Probst C
Acta Ophthalmol; 2021 Dec; 99(8):e1366-e1374. PubMed ID: 33890418
[TBL] [Abstract][Full Text] [Related]
6. A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes.
Lode HE; Gjølberg TT; Foss S; Sivertsen MS; Brustugun J; Andersson Y; Jørstad ØK; Moe MC; Andersen JT
Sci Rep; 2019 Dec; 9(1):18021. PubMed ID: 31792234
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab.
Crul M; Zandvliet A; Moes JR; Veenbaas T; Smeets O
J Ocul Pharmacol Ther; 2019; 35(6):372-375. PubMed ID: 31259653
[No Abstract] [Full Text] [Related]
8. PARTICULATE MATTER FROM SYRINGES USED FOR INTRAVITREAL INJECTIONS.
Dounce SM; Laskina O; Goldberg RA
Retina; 2021 Apr; 41(4):827-833. PubMed ID: 32956210
[TBL] [Abstract][Full Text] [Related]
9. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling.
Liu L; Ammar DA; Ross LA; Mandava N; Kahook MY; Carpenter JF
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1023-34. PubMed ID: 21051703
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal silicone oil droplets after intravitreal drug injections.
Bakri SJ; Ekdawi NS
Retina; 2008; 28(7):996-1001. PubMed ID: 18698303
[TBL] [Abstract][Full Text] [Related]
11. Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration.
Paul M; Vieillard V; Roumi E; Cauvin A; Despiau MC; Laurent M; Astier A
Ann Pharm Fr; 2012 May; 70(3):139-54. PubMed ID: 22655582
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Syringes With Intravitreal Anti-VEGF Drugs: Particle Burden and Protein Aggregates in Brolucizumab, Aflibercept and Bevacizumab.
Schargus M; Kopp KT; Helbig C; Frings A; Winter G
Transl Vis Sci Technol; 2021 Aug; 10(9):21. PubMed ID: 34406342
[TBL] [Abstract][Full Text] [Related]
13. LARGE SILICONE DROPLETS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN).
Avery RL; Castellarin AA; Dhoot DS; Pieramici DJ; Nasir MA; Steinle NC; Avery LP; Gordon GM
Retin Cases Brief Rep; 2019 Spring; 13(2):130-134. PubMed ID: 28301412
[TBL] [Abstract][Full Text] [Related]
14. LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS.
Peterson JS; Rockwell K; Scott IU; Ip MS; VanVeldhuisen PC; Blodi BA;
Retina; 2019 Sep; 39(9):1802-1809. PubMed ID: 29746405
[TBL] [Abstract][Full Text] [Related]
15. Silicone oil droplets after intravitreal bevacizumab injection in two patients.
Caroca JO; Caroca JIO
Arch Soc Esp Oftalmol (Engl Ed); 2020 Jun; 95(6):e43. PubMed ID: 32376125
[No Abstract] [Full Text] [Related]
16. SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.
Scott IU; Oden NL; VanVeldhuisen PC; Ip MS; Blodi BA; Antoszyk AN;
Am J Ophthalmol; 2009 Nov; 148(5):725-732.e7. PubMed ID: 19674727
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of syringe surfaces on protein formulations.
Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the risk of needlestick injuries associated with intravitreal injections.
Shah SU; Koenig MJ; Dacquay Y; Mozayan A; Hubschman JP
Retina; 2014 Apr; 34(4):781-4. PubMed ID: 23975000
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the initial level and migration of silicone oil lubricant in empty prefilled syringes for biologics using infrared spectroscopy.
Bee JS; Frey VV; Javed U; Chung J; Corcoran ML; Roussel PS; Krause SO; Cash PW; Bishop SM; Dimitrova MN
PDA J Pharm Sci Technol; 2014; 68(5):494-503. PubMed ID: 25336420
[TBL] [Abstract][Full Text] [Related]
20. Prefilled syringes for intravitreal injection reduce preparation time.
Subhi Y; Kjer B; Munch IC
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
